Hyperglycemia induces activation of the transcription factor NF-kappa B in ex vivo-isolated PBMCs of patients with type 1 diabetes. NF-kappa B activation is at least partially dependent on oxidative stress, since the antioxidant thioctic acid significantly lowered the extent of NF-kappa B binding activity.
Increased oxidative stress generated by hyperglycaemia, hyperlipidaemia or the presence of advanced glycation endproducts (AGEs) or both is regarded as an important mediator of late diabetic complications [1]. A clear relation between the quality of glycaemic control and the presence of free radicals has been shown thereby relating the appearance of oxidative stress to the underlying metabolic disorder rather than to the complication itself [2]. The presence of oxygen free radicals and the simultaneous decline of antioxidative defence mechanisms observed in diabetic patients could therefore promote the development of late diabetic complications [1, 3±5].Oxidative stress has been proposed as a major cause of diabetic nephropathy [6±9]. Animal models implicate that oxidative stress accompanying the early onset of diabetes increases the kidney's susceptibility to develop diabetic nephropathy [10]. One possible mechanism for this is the activation of the oxidative stress sensitive transcription factor NF-kB [6, 11±13]. Translocation of activated NF-kB into the nucleus results in gene expression of NF-kB controlled Diabetologia (1999) 42: 222±232 Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kB
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.